AMCP’s Andel Talks Drug Pricing Proposals Ahead of Election
April 24, 2020
Melissa Andel, Applied Policy vice president of health policy, discussed during an AMCP eLearning Days presentation drug pricing proposals in the U.S. as the 2020 election nears.
According to an eLearning Days post, Andel highlighted how Trump has acted on drug pricing during his presidency, including changes to Medicare Part B.
To read more, click here.
